حمل تطبيق فيزيتا الآن ادخل بروموكود PH15 واحصل على أوسع تغطية، تتبع فوري لطلباتك، وتجربة سلسة ومريحة - كل ذلك في تطبيق واحد.
حمل التطبيق الآن
Ciprapro 10 Mg - 30 F.C. Tablets
Box
هذه الصفحة قد لا تغطي جميع المعلومات المذكورة في نشرة الشركة المصنعة المرفقة
الوصف الطبي
Antidepressant, selective serotonin reuptake inhibitor used in the treatment of major depressive disorder, obsessive-compulsive disorder, posttraumatic stress disorder, panic disorder and generalized anxiety disorder.
الدلالة و الاستخدام
-Major depressive disorder (unipolar): Oral: Initial: 10 mg once daily; dose may be increased in 10 mg increments after ≥1 week based on response and tolerability up to a maximum dose of 20 mg once daily; however, doses up to 30 mg/day are used in practice and may provide further benefit.
-Obsessive-compulsive disorder (OCD): Oral: Initial: 10 mg once daily; dose may be increased in 10 mg increments at intervals ≥1 week up to 40 mg once daily.
-Panic disorder: Oral: Initial: 5 mg once daily for 3 to 7 days, then increase dose to 10 mg once daily. May further increase at intervals ≥1 week to 20 mg once daily based on response and tolerability.
-Posttraumatic stress disorder: Oral: Initial: 10 mg once daily; may gradually increase dose based on response and tolerability up to 40 mg once daily.
-Binge eating disorder: Based on limited data: Oral: Initial: 10 mg once daily; may increase based on response and tolerability in 10 mg increments at intervals ≥1 week up to 30 mg/day.
-Pediatric dosing: Depression: Oral: Children and Adolescents ≥12 years: Initial: 10 mg once daily; may be increased to 20 mg/day after at least 3 weeks. Autism and Pervasive Developmental Disorders (PDD): Limited data available: Oral: Children and Adolescents 6 to 17 years: Initial: 2.5 mg once daily; may increase if needed to 5 mg/day after 1 week; may then increase at weekly intervals by 5 mg/day if needed and as tolerated; maximum dose: 20 mg/day.